Healx Limited operates as a biotechnology company. The Company develops pharmaceutical products to find new therapeutic solutions for patients with rare diseases. Healx serves patients in the United Kingdom.
Every round, secondary, debt facility or acquisition involving Healx that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.